DRREDDY had a strong weekly performance, with a return of 5.74%, significantly outperforming its peers. The stock's volatility was high at 23.85%, indicating a risky investment. Despite the risk, the stock's Sharpe Ratio of 0.94 suggests that the return was relatively stable. Compared to its peers, DRREDDY outperformed DIVISLAB, SUNPHARMA, and HINDUNILVR, making it a top performer in the sector.

[Volatility: 23.85%]